Colony »

Allogene Therapeutics shares owned by Colony

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Colony from 13F filings

Historical chart of Colony investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Colony consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Colony

Quarter filed Position value Share count Share price at filing
2026-03-31 $47k 19k 2.44

More positions owned by Colony

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr State Street Tec (XLK)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Valued Advisers Tr Kovitz Core Eqt (EQTY)
Broadcom (AVGO)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ea Series Trust Ea Bridgeway Omn (BSVO)

View all positions for Colony

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
State Street Corporation
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
T. Rowe Price Associates
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Marshall Wace
Millennium Management

View all funds holding Allogene Therapeutics